HRB HR Block reports narrower Q1 2026 per share loss than estimates dips 025 percent in todays trading Why is Tenaya Therapeutics TNYA stock gaining attention recently Q4 2025 Better Than Expected CWD CaliberCos stock falls 189 after Q4 2025 EPS lands far below consensus analyst estimates Is Kiniksa KNSA stock still in expansion phase Kiniksa Posts 315 EPS Beat Topping Consensus HPEC Hewlett leadership prioritizes AI infrastructure rollouts to drive longterm shareholder value in coming quarters Gilead Sciences GILD Valuation Implications of Expanded Kymera Therapeutics Collaboration and Kymeras FDA Fast Track Designation Halliburton Company HAL Q1 2026 Earnings Beat And New International Contract Wins Drive 7 Intraday Upside NEO NeoGenomics delivers 389 percent Q1 2026 EPS beat but shares fall 067 percent in todays trading EOS Eaton investors await full quarterly earnings details as management teases longterm strategic investment plans